Perspective - (2025) Volume 16, Issue 3
Received: 02-Jun-2025, Manuscript No. jbsbe-26-183302;
Editor assigned: 04-Jun-2025, Pre QC No. P-183302;
Reviewed: 18-Jun-2025, QC No. Q-183302;
Revised: 23-Jun-2025, Manuscript No. R-183302;
Published:
30-Jun-2025
, DOI: 10.37421/2165-6210.2025.16.508
Citation: Johansson, Erik. ”Advancements In Biosensor Technology For Neural Monitoring.” J Biosens Bioelectron 16 (2025):508.
Copyright: © 2025 Johansson E. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
The field of biosensing has witnessed significant advancements, particularly in the development of technologies for monitoring neurotransmitters and neural activity in real-time. These innovations are crucial for understanding complex neurological processes and for the potential diagnosis and management of various disorders. Recent research has focused on enhancing the sensitivity, selectivity, and in vivo applicability of these biosensors, paving the way for more detailed insights into brain function. This article explores the development and application of biosensors designed for real-time monitoring of neurotransmitters and neural activity. It highlights advancements in materials, electrode designs, and detection methods that enable high sensitivity and selectivity for these crucial biological signals. The focus is on in vivo applications, particularly in neuroscience research and potentially in clinical settings for diagnosing and managing neurological disorders. [1] The development of novel electrochemical biosensors employing nanomaterials has shown great promise for the enhanced detection of key neurotransmitters like dopamine and serotonin. These nanomaterial-based approaches offer improved performance characteristics, which are essential for accurate in vivo measurements. This research details novel electrochemical biosensors fabricated using nanomaterials for enhanced detection of dopamine and serotonin. The study emphasizes the importance of surface functionalization to improve sensor stability and minimize interference from other biological molecules. Applications discussed include tracking neurotransmitter dynamics in freely moving animals. [2] Miniaturization and power efficiency are critical considerations for the long-term and minimally invasive monitoring of neural signals and neurotransmitter release. Wireless micro-biosensor systems are emerging as a powerful solution to address these challenges, enabling continuous data acquisition. The authors present a wireless micro-biosensor system for continuous monitoring of neural signals and neurotransmitter release. This work focuses on miniaturization and power efficiency, enabling long-term implantation with minimal invasiveness. The system integrates sensing elements with wireless communication capabilities for data acquisition and transmission. [3] Flexible biosensors represent a significant leap forward in neural interface technology. Their inherent ability to conform to delicate neural tissues can lead to reduced mechanical mismatch and inflammation, thereby improving the longevity and reliability of neural implants. This review article synthesizes recent progress in the field of flexible biosensors for neural interfaces. It discusses the advantages of flexible materials in conforming to neural tissues, reducing mechanical mismatch and inflammation. The review covers various sensing modalities, including electrochemical, optical, and mechanical, for neurotransmitter detection and neuronal signal recording. [4] Specific neurotransmitters, such as glutamate, play vital roles in neural function and are implicated in various neurological conditions. The development of highly sensitive and selective enzyme-based biosensors is essential for precisely quantifying glutamate levels in complex biological environments. The paper introduces a novel enzyme-based biosensor for the detection of glutamate, a key excitatory neurotransmitter. The sensor utilizes a highly selective enzyme immobilization technique on a modified electrode surface to achieve rapid and sensitive measurements. Potential applications in understanding excitotoxicity and neurodegenerative diseases are discussed. [5] Integrating microfluidic technologies with neural interfaces offers a sophisticated approach to simultaneously capture both electrical activity and neurochemical information. This integrated platform allows for a more comprehensive understanding of neural dynamics. This study reports the development of a microfluidic biosensor integrated with a neural interface for simultaneous recording of electrical activity and neurotransmitter levels. The system employs advanced microfabrication techniques and addresses challenges related to electrode fouling and signal drift in chronic implantation scenarios. [6] Conducting polymers possess unique electrochemical properties that make them highly suitable for constructing high-performance biosensors. Their tunable characteristics can be exploited to enhance signal transduction and integration with biological systems, particularly for neurotransmitter monitoring. The authors investigate the use of conducting polymers in the fabrication of highly sensitive and stable biosensors for neurotransmitters. The unique electrochemical properties of these polymers allow for improved signal transduction and integration with biological systems. The article discusses their potential for chronic in vivo monitoring applications. [7] Optical biosensors, particularly those employing surface plasmon resonance (SPR), provide a label-free and real-time method for detecting neurochemical interactions. This technology is invaluable for high-throughput screening and studying complex neurochemical dynamics. The paper presents a novel optical biosensor for real-time, label-free detection of neurotransmitter binding events. The sensor leverages surface plasmon resonance (SPR) technology and is designed for high-throughput screening and monitoring of neurochemical interactions in complex biological environments. [8] Assessing neural excitability is fundamental to understanding brain function and dysfunction. Monitoring extracellular ion concentrations, which are intrinsically linked to neurotransmitter activity, offers an indirect yet powerful method for evaluating neural excitability through implantable biosensors. The study focuses on developing implantable biosensors capable of detecting changes in neural excitability by monitoring extracellular ion concentrations, which are closely linked to neurotransmitter activity. The research emphasizes the use of biocompatible materials and miniaturized architectures for long-term in vivo performance. [9] The complexity and invasiveness of current neurotransmitter monitoring systems can be significantly reduced by developing self-powered biosensor platforms. Such systems can integrate multiple sensing capabilities with integrated power generation, enabling continuous and less disruptive brain monitoring. This work presents a novel, self-powered biosensor system for monitoring multiple neurotransmitters simultaneously in the brain. The device integrates a micro-enzyme fuel cell with microelectrode arrays, enabling continuous power generation and detection of dopamine, glutamate, and GABA. This approach significantly reduces the complexity and invasiveness of existing monitoring systems. [10]
The ongoing pursuit of advanced biosensing technologies is fundamentally driven by the need for precise and continuous monitoring of crucial biological signals, particularly neurotransmitters and neural activity. These biological markers are central to brain function and are implicated in a wide array of neurological conditions. Significant efforts are being directed towards developing sophisticated biosensors that not only exhibit high sensitivity and selectivity but are also amenable to in vivo applications, thereby offering unprecedented insights into the dynamic processes occurring within the brain. The advancements encompass innovative materials, refined electrode designs, and novel detection methodologies. This article explores the development and application of biosensors designed for real-time monitoring of neurotransmitters and neural activity. It highlights advancements in materials, electrode designs, and detection methods that enable high sensitivity and selectivity for these crucial biological signals. The focus is on in vivo applications, particularly in neuroscience research and potentially in clinical settings for diagnosing and managing neurological disorders. [1] A key area of innovation involves the fabrication of electrochemical biosensors incorporating nanomaterials. These materials offer enhanced surface area and unique electronic properties, leading to improved detection capabilities for neurotransmitters such as dopamine and serotonin. Furthermore, meticulous surface functionalization plays a critical role in bolstering sensor stability and minimizing interference from confounding biological molecules, which is paramount for reliable in vivo measurements. This research details novel electrochemical biosensors fabricated using nanomaterials for enhanced detection of dopamine and serotonin. The study emphasizes the importance of surface functionalization to improve sensor stability and minimize interference from other biological molecules. Applications discussed include tracking neurotransmitter dynamics in freely moving animals. [2] The trend towards miniaturization and enhanced power efficiency is paramount for the development of implantable biosensor systems that facilitate long-term, minimally invasive monitoring of neural signals and neurotransmitter release. Wireless micro-biosensor systems represent a significant stride in this direction, integrating sophisticated sensing elements with robust wireless communication capabilities to enable continuous data acquisition and transmission from within the biological system. The authors present a wireless micro-biosensor system for continuous monitoring of neural signals and neurotransmitter release. This work focuses on miniaturization and power efficiency, enabling long-term implantation with minimal invasiveness. The system integrates sensing elements with wireless communication capabilities for data acquisition and transmission. [3] The integration of flexible materials into biosensor design has revolutionized the development of neural interfaces. The inherent conformability of these flexible biosensors to neural tissues allows for a superior mechanical interface, reducing the potential for tissue damage and inflammatory responses. This improved biocompatibility is crucial for chronic implantation and sustained monitoring. This review article synthesizes recent progress in the field of flexible biosensors for neural interfaces. It discusses the advantages of flexible materials in conforming to neural tissues, reducing mechanical mismatch and inflammation. The review covers various sensing modalities, including electrochemical, optical, and mechanical, for neurotransmitter detection and neuronal signal recording. [4] Targeted detection of specific neurotransmitters, such as glutamate, which is a principal excitatory neurotransmitter, is of considerable interest due to its role in synaptic plasticity and its implication in neurodegenerative conditions. Enzyme-based biosensors, employing highly selective enzyme immobilization techniques on modified electrode surfaces, are being developed to achieve rapid and sensitive measurements of glutamate, offering potential applications in studying excitotoxicity. The paper introduces a novel enzyme-based biosensor for the detection of glutamate, a key excitatory neurotransmitter. The sensor utilizes a highly selective enzyme immobilization technique on a modified electrode surface to achieve rapid and sensitive measurements. Potential applications in understanding excitotoxicity and neurodegenerative diseases are discussed. [5] The convergence of microfluidic technologies and neural interfaces presents a powerful paradigm for simultaneous in vivo monitoring. These integrated systems enable the concurrent recording of both electrical neuronal activity and the concentration of key neurotransmitters. Such multi-modal sensing approaches are critical for a holistic understanding of complex neural circuit dynamics and for addressing challenges associated with electrode fouling and signal integrity. This study reports the development of a microfluidic biosensor integrated with a neural interface for simultaneous recording of electrical activity and neurotransmitter levels. The system employs advanced microfabrication techniques and addresses challenges related to electrode fouling and signal drift in chronic implantation scenarios. [6] Conducting polymers are emerging as highly versatile materials for the fabrication of advanced biosensors, particularly for neurotransmitter detection. Their inherent electrical conductivity and tunable electrochemical properties facilitate efficient signal transduction and seamless integration with biological interfaces. The application of conducting polymers holds significant promise for developing robust and sensitive biosensors capable of chronic in vivo monitoring. The authors investigate the use of conducting polymers in the fabrication of highly sensitive and stable biosensors for neurotransmitters. The unique electrochemical properties of these polymers allow for improved signal transduction and integration with biological systems. The article discusses their potential for chronic in vivo monitoring applications. [7] Optical biosensing methodologies, specifically those utilizing surface plasmon resonance (SPR), offer a label-free and real-time detection mechanism for critical neurochemical events. This technology is well-suited for high-throughput screening and offers a sensitive platform for monitoring neurochemical interactions within complex biological matrices without the need for exogenous labeling. The paper presents a novel optical biosensor for real-time, label-free detection of neurotransmitter binding events. The sensor leverages surface plasmon resonance (SPR) technology and is designed for high-throughput screening and monitoring of neurochemical interactions in complex biological environments. [8] The assessment of neural excitability, a fundamental parameter in understanding brain function and disease, can be effectively achieved through the monitoring of extracellular ion concentrations. These ion fluctuations are intrinsically linked to neurotransmitter activity, and implantable biosensors designed with biocompatible materials and miniaturized architectures are being developed for reliable, long-term in vivo performance in this regard. The study focuses on developing implantable biosensors capable of detecting changes in neural excitability by monitoring extracellular ion concentrations, which are closely linked to neurotransmitter activity. The research emphasizes the use of biocompatible materials and miniaturized architectures for long-term in vivo performance. [9] The development of self-powered biosensor systems represents a paradigm shift in the field, addressing the limitations of external power sources and reducing the invasiveness of monitoring devices. By integrating micro-enzyme fuel cells with microelectrode arrays, these novel systems can generate their own power while simultaneously detecting multiple neurotransmitters, thereby simplifying complex monitoring setups and enhancing long-term in vivo applicability. This work presents a novel, self-powered biosensor system for monitoring multiple neurotransmitters simultaneously in the brain. The device integrates a micro-enzyme fuel cell with microelectrode arrays, enabling continuous power generation and detection of dopamine, glutamate, and GABA. This approach significantly reduces the complexity and invasiveness of existing monitoring systems. [10]
Recent advancements in biosensor technology are enabling real-time monitoring of neurotransmitters and neural activity. Innovations in materials, electrode design, and detection methods have led to highly sensitive and selective biosensors for in vivo applications. Nanomaterial-based electrochemical biosensors show promise for dopamine and serotonin detection, while wireless micro-biosensor systems offer minimally invasive, long-term monitoring. Flexible biosensors are improving neural interfaces by reducing tissue irritation. Enzyme-based sensors are being developed for specific neurotransmitters like glutamate, and microfluidic systems integrate neural interfaces for simultaneous electrical and chemical recording. Conducting polymers enhance biosensor performance, and optical methods like SPR allow label-free detection. Implantable biosensors monitor ion concentrations for neural excitability assessment, and self-powered systems are emerging for simultaneous multi-neurotransmitter detection, reducing invasiveness.
None
None
Biosensors & Bioelectronics received 6207 citations as per Google Scholar report
